S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
Rivian shares gets discounted; shares can move lower 
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
The Trade Desk: 3 reasons to buy before a new all-time high
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard

Fulcrum Therapeutics (FULC) Short Interest Ratio & Short Volume

$9.55
0.00 (0.00%)
(As of 02/22/2024 ET)

Fulcrum Therapeutics Short Interest Data

Current Short Volume
3,380,000 shares
Previous Short Volume
4,040,000 shares
Change Vs. Previous Month
-16.34%
Dollar Volume Sold Short
$24.40 million
Short Interest Ratio / Days to Cover
5.5
Last Record Date
January 31, 2024
Outstanding Shares
61,820,000 shares
Percentage of Shares Shorted
5.47%
Today's Trading Volume
247,324 shares
Average Trading Volume
517,907 shares
Today's Volume Vs. Average
48%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Fulcrum Therapeutics ?

Sign up to receive the latest short interest report for Fulcrum Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

FULC Short Interest Over Time

FULC Days to Cover Over Time

FULC Percentage of Float Shorted Over Time


Fulcrum Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20243,380,000 shares $24.40 million -16.3%N/A5.5 $7.22
1/15/20244,040,000 shares $28.68 million +10.1%N/A6.7 $7.10
12/31/20233,670,000 shares $24.77 million +10.2%N/A6.5 $6.75
12/15/20233,330,000 shares $17.95 million -18.0%N/A6.2 $5.39
11/30/20234,060,000 shares $19.49 million +9.7%N/A7.8 $4.80
11/15/20233,700,000 shares $15.47 million -6.3%N/A6.1 $4.18
10/31/20233,950,000 shares $14.38 million +1.0%N/A2 $3.64
10/15/20233,910,000 shares $15.21 million -2.7%N/A1.9 $3.89
9/30/20234,020,000 shares $17.85 million +7.5%N/A2 $4.44
9/15/20233,740,000 shares $16.79 million +5.1%N/A1.8 $4.49
8/31/20233,560,000 shares $19.69 million +30.4%N/A1.7 $5.53
8/15/20232,730,000 shares $11.55 million -22.2%N/A1.3 $4.23
7/31/20233,510,000 shares $13.41 million +0.3%N/A5 $3.82
7/15/20233,500,000 shares $12.88 million -4.1%N/A4.6 $3.68
6/30/20233,650,000 shares $12.05 million -19.3%N/A4.6 $3.30
6/15/20234,520,000 shares $13.74 million +9.4%N/A5.3 $3.04
5/31/20234,130,000 shares $11.23 million +4.8%N/A4.1 $2.72
5/15/20233,940,000 shares $14.34 million -17.6%N/A3.2 $3.64
4/30/20234,780,000 shares $11.95 million -6.6%N/A3.9 $2.50
4/15/20235,120,000 shares $12.34 million +3.6%N/A4.2 $2.41
3/31/20234,940,000 shares $14.08 million +25.1%N/A3.8 $2.85
3/15/20233,950,000 shares $15.01 million -2.5%N/A3.1 $3.80
2/28/20234,050,000 shares $24.46 million +7.7%N/A3.8 $6.04
2/15/20233,760,000 shares $48.69 million +6.2%N/A3.8 $12.95
1/31/20233,540,000 shares $44.64 million +6.6%N/A4.6 $12.61
1/15/20233,320,000 shares $45.48 million -7.3%N/A4.6 $13.70
12/30/20223,580,000 shares $26.06 million +21.0%N/A5.7 $7.28
12/15/20222,960,000 shares $16.22 million -9.2%N/A6.1 $5.48
11/30/20223,260,000 shares $22.33 million -4.4%N/A8.5 $6.85
11/15/20223,410,000 shares $24.48 million -2.0%N/A8.9 $7.18
10/31/20223,480,000 shares $19.35 million +0.6%N/A8 $5.56
10/15/20223,460,000 shares $25.95 million -3.9%N/A7.5 $7.50
9/30/20223,600,000 shares $29.12 million -7.2%N/A8.4 $8.09
9/15/20223,880,000 shares $35.31 million +13.8%N/A8.4 $9.10
8/31/20223,410,000 shares $25.23 million +5.3%N/A5.3 $7.40
8/15/20223,240,000 shares $25.34 million -8.2%N/A4.6 $7.82
7/31/20223,530,000 shares $20.76 million -6.1%12.0%4.8 $5.88
7/15/20223,760,000 shares $20.27 million +1.4%12.8%5.1 $5.39
6/30/20223,710,000 shares $18.18 million +6.6%12.6%4.3 $4.90
6/15/20223,480,000 shares $15.35 million -7.0%11.8%3.9 $4.41













FULC Short Interest - Frequently Asked Questions

What is Fulcrum Therapeutics' current short interest?

Short interest is the volume of Fulcrum Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 3,380,000 shares of FULC short. Learn More on Fulcrum Therapeutics' current short interest.

What is a good short interest ratio for Fulcrum Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FULC shares currently have a short interest ratio of 6.0. Learn More on Fulcrum Therapeutics's short interest ratio.

Which institutional investors are shorting Fulcrum Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Fulcrum Therapeutics: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Fulcrum Therapeutics' short interest increasing or decreasing?

Fulcrum Therapeutics saw a decrease in short interest in January. As of January 31st, there was short interest totaling 3,380,000 shares, a decrease of 16.3% from the previous total of 4,040,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Fulcrum Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Fulcrum Therapeutics: Phathom Pharmaceuticals, Inc. (32.43%), Ocular Therapeutix, Inc. (4.99%), Biomea Fusion, Inc. (33.47%), Astria Therapeutics, Inc. (5.25%), Travere Therapeutics, Inc. (13.21%), Calliditas Therapeutics AB (publ) (0.02%), Mineralys Therapeutics, Inc. (4.27%), COMPASS Pathways plc (5.74%), Lyell Immunopharma, Inc. (9.42%), Larimar Therapeutics, Inc. (0.77%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Fulcrum Therapeutics stock?

Short selling FULC is an investing strategy that aims to generate trading profit from Fulcrum Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Fulcrum Therapeutics?

A short squeeze for Fulcrum Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FULC, which in turn drives the price of the stock up even further.

How often is Fulcrum Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FULC, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:FULC) was last updated on 2/23/2024 by MarketBeat.com Staff